← Back to Clinical Trials
Recruiting NCT06653036

NCT06653036 Dural Puncture Epidural Vs Standard Epidural Technique in Parturient Receiving Continuous Labour Epidural Infusion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06653036
Status Recruiting
Phase
Sponsor Aga Khan University
Condition Quality Health Care
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2024-11-28
Primary Completion 2025-11-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Dural puncture epiduralStandard Epidural Technique

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2024-11-28 with a primary completion date of 2025-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to evaluate the quality and safety of labor analgesia by comparing the use of Dural puncture epidural technique to Standard epidural technique while maintaining labor analgesia by means of continuous epidural infusion in parturient. The main questions it aims to answer are * Effectiveness and quality of labor analgesia * Frequency of catheter adjustments * Need for catheter replacements * Incidence of failed regional anesthesia requiring conversion to general anesthesia

Eligibility Criteria

Inclusion Criteria: * Nulliparous / Multiparous women * Age \>18 years * ASA 1 \& 2 * Singleton vertex presentation * Gestational age 37-42 weeks * Parturient with established labor and pain score ≥ 3 Exclusion Criteria: * Major cardiac disease * History of chronic pain * Chronic opioid user * Platelet count \< 70 x 109/L * spinal cord anomalies * Use of anticoagulants * Allergic to local anesthetics * Patients with preeclampsia/ eclampsia * Known fetal anomalies

Contact & Investigator

Central Contact

Samina Ismail, MBBS, FCPS

✉ samina.ismail@aku.edu

📞 +922134864331

Frequently Asked Questions

Who can join the NCT06653036 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Quality Health Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06653036 currently recruiting?

Yes, NCT06653036 is actively recruiting participants. Contact the research team at samina.ismail@aku.edu for enrollment information.

Where is the NCT06653036 trial being conducted?

This trial is being conducted at Karachi, Pakistan.

Who is sponsoring the NCT06653036 clinical trial?

NCT06653036 is sponsored by Aga Khan University. The trial plans to enroll 38 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology